INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 222 filers reported holding INSMED INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969 | -30.7% | 38,387 | -53.2% | 0.08% | -39.9% |
| Q1 2023 | $1,399 | +12.6% | 82,072 | +32.0% | 0.14% | -10.4% |
| Q4 2022 | $1,242 | -99.9% | 62,184 | -27.3% | 0.15% | -36.9% |
| Q3 2022 | $1,842,000 | +544.1% | 85,531 | +603.8% | 0.24% | +542.1% |
| Q1 2022 | $286,000 | -58.4% | 12,152 | -39.8% | 0.04% | -66.7% |
| Q1 2021 | $687,000 | +56.1% | 20,182 | +52.6% | 0.11% | +58.3% |
| Q4 2020 | $440,000 | -84.6% | 13,224 | -85.1% | 0.07% | -84.9% |
| Q3 2020 | $2,861,000 | +626.1% | 89,029 | +299.1% | 0.48% | +800.0% |
| Q3 2019 | $394,000 | -37.0% | 22,310 | +3.7% | 0.05% | -15.9% |
| Q1 2019 | $625,000 | +1.1% | 21,513 | +8.5% | 0.06% | +65.8% |
| Q4 2017 | $618,000 | +17.9% | 19,824 | +18.0% | 0.04% | +5.6% |
| Q3 2017 | $524,000 | +39.4% | 16,794 | -19.0% | 0.04% | +100.0% |
| Q4 2015 | $376,000 | -54.9% | 20,742 | -53.8% | 0.02% | -56.1% |
| Q3 2015 | $834,000 | – | 44,893 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |